These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 8843907

  • 1. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.
    Sartani G, Silver PB, Rizzo LV, Chan CC, Wiggert B, Mastorakos G, Caspi RR.
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2211-8. PubMed ID: 8843907
    [Abstract] [Full Text] [Related]

  • 2. Effects of systemic and intravitreal TNF-α inhibition in experimental autoimmune uveoretinitis.
    Busch M, Bauer D, Hennig M, Wasmuth S, Thanos S, Heiligenhaus A.
    Invest Ophthalmol Vis Sci; 2013 Jan 02; 54(1):39-46. PubMed ID: 23211816
    [Abstract] [Full Text] [Related]

  • 3. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H, Strassmann G, Chan CC, Rizzo LV, Silver PB, Wiggert B, Caspi RR.
    Invest Ophthalmol Vis Sci; 1999 Apr 02; 40(5):942-50. PubMed ID: 10102291
    [Abstract] [Full Text] [Related]

  • 4. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
    Hohki S, Ohguro N, Haruta H, Nakai K, Terabe F, Serada S, Fujimoto M, Nomura S, Kawahata H, Kishimoto T, Naka T.
    Exp Eye Res; 2010 Aug 02; 91(2):162-70. PubMed ID: 20420831
    [Abstract] [Full Text] [Related]

  • 5. Administration of a peptide inhibitor of alpha4-integrin inhibits the development of experimental autoimmune uveitis.
    Martín AP, de Moraes LV, Tadokoro CE, Commodaro AG, Urrets-Zavalia E, Rabinovich GA, Urrets-Zavalia J, Rizzo LV, Serra HM.
    Invest Ophthalmol Vis Sci; 2005 Jun 02; 46(6):2056-63. PubMed ID: 15914623
    [Abstract] [Full Text] [Related]

  • 6. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.
    Avichezer D, Silver PB, Chan CC, Wiggert B, Caspi RR.
    Invest Ophthalmol Vis Sci; 2000 Jan 02; 41(1):127-31. PubMed ID: 10634611
    [Abstract] [Full Text] [Related]

  • 7. Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12.
    Yokoi H, Kato K, Kezuka T, Sakai J, Usui M, Yagita H, Okumura K.
    Eur J Immunol; 1997 Mar 02; 27(3):641-6. PubMed ID: 9079803
    [Abstract] [Full Text] [Related]

  • 8. The role of tumor necrosis factor-alpha in the induction of experimental autoimmune uveoretinitis in mice.
    Nakamura S, Yamakawa T, Sugita M, Kijima M, Ishioka M, Tanaka S, Ohno S.
    Invest Ophthalmol Vis Sci; 1994 Oct 02; 35(11):3884-9. PubMed ID: 7928185
    [Abstract] [Full Text] [Related]

  • 9. Everolimus improves experimental autoimmune uveoretinitis.
    Hennig M, Bauer D, Wasmuth S, Busch M, Walscheid K, Thanos S, Heiligenhaus A.
    Exp Eye Res; 2012 Dec 02; 105():43-52. PubMed ID: 23059401
    [Abstract] [Full Text] [Related]

  • 10. Adoptive transfer of experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein.
    Kawashima H, Fujiño Y, Mochizuki M.
    Jpn J Ophthalmol; 1991 Dec 02; 35(1):51-60. PubMed ID: 1895569
    [Abstract] [Full Text] [Related]

  • 11. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
    Caspi RR, Roberge FG, Chan CC, Wiggert B, Chader GJ, Rozenszajn LA, Lando Z, Nussenblatt RB.
    J Immunol; 1988 Mar 01; 140(5):1490-5. PubMed ID: 3346541
    [Abstract] [Full Text] [Related]

  • 12. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.
    Silver PB, Chan CC, Wiggert B, Caspi RR.
    Invest Ophthalmol Vis Sci; 1999 Nov 01; 40(12):2898-905. PubMed ID: 10549650
    [Abstract] [Full Text] [Related]

  • 13. Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate.
    Kitamei H, Iwabuchi K, Namba K, Yoshida K, Yanagawa Y, Kitaichi N, Kitamura M, Ohno S, Onoé K.
    J Leukoc Biol; 2006 Jun 01; 79(6):1193-201. PubMed ID: 16574770
    [Abstract] [Full Text] [Related]

  • 14. Suramin treatment suppresses induction of experimental autoimmune uveoretinitis (EAU) in rodents.
    Sartani G, Silver PB, Strassmann G, Chan CC, Caspi RR.
    Curr Eye Res; 1995 Oct 01; 14(10):887-96. PubMed ID: 8549154
    [Abstract] [Full Text] [Related]

  • 15. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
    Jiang HR, Wei X, Niedbala W, Lumsden L, Liew FY, Forrester JV.
    Invest Ophthalmol Vis Sci; 2001 Jan 01; 42(1):177-82. PubMed ID: 11133864
    [Abstract] [Full Text] [Related]

  • 16. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
    Kohno H, Sakai T, Tsuneoka H, Imanishi K, Saito S.
    Exp Eye Res; 2009 Oct 01; 89(4):486-93. PubMed ID: 19523946
    [Abstract] [Full Text] [Related]

  • 17. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.
    Keino H, Kezuka T, Takeuchi M, Yamakawa N, Hattori T, Usui M.
    Arch Ophthalmol; 2004 Aug 01; 122(8):1179-84. PubMed ID: 15302659
    [Abstract] [Full Text] [Related]

  • 18. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
    Egwuagu CE, Mahdi RM, Nussenblatt RB, Gery I, Caspi RR.
    J Immunol; 1993 Aug 01; 151(3):1627-36. PubMed ID: 8393049
    [Abstract] [Full Text] [Related]

  • 19. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H, Ohguro N, Fujimoto M, Hohki S, Terabe F, Serada S, Nomura S, Nishida K, Kishimoto T, Naka T.
    Invest Ophthalmol Vis Sci; 2011 May 17; 52(6):3264-71. PubMed ID: 21330657
    [Abstract] [Full Text] [Related]

  • 20. Suppression of experimental autoimmune uveoretinitis by Anti-IL-17 antibody.
    Zhang R, Qian J, Guo J, Yuan YF, Xue K.
    Curr Eye Res; 2009 Apr 17; 34(4):297-303. PubMed ID: 19373578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.